Report Overview
This report provides a deep insight into the global Metabotropic Glutamate Receptor 2 market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Metabotropic Glutamate Receptor 2 Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Metabotropic Glutamate Receptor 2 market in any manner.
Global Metabotropic Glutamate Receptor 2 Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
Market Segmentation (by Type)
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Market Segmentation (by Application)
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Metabotropic Glutamate Receptor 2 Market
? Overview of the regional outlook of the Metabotropic Glutamate Receptor 2 Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Metabotropic Glutamate Receptor 2 Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Metabotropic Glutamate Receptor 2
1.2 Key Market Segments
1.2.1 Metabotropic Glutamate Receptor 2 Segment by Type
1.2.2 Metabotropic Glutamate Receptor 2 Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Metabotropic Glutamate Receptor 2 Market Overview
2.1 Global Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 2 Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Metabotropic Glutamate Receptor 2 Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Metabotropic Glutamate Receptor 2 Market Competitive Landscape
3.1 Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers (2019-2024)
3.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2019-2024)
3.3 Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Metabotropic Glutamate Receptor 2 Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Metabotropic Glutamate Receptor 2 Sales Sites, Area Served, Product Type
3.6 Metabotropic Glutamate Receptor 2 Market Competitive Situation and Trends
3.6.1 Metabotropic Glutamate Receptor 2 Market Concentration Rate
3.6.2 Global 5 and 10 Largest Metabotropic Glutamate Receptor 2 Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Metabotropic Glutamate Receptor 2 Industry Chain Analysis
4.1 Metabotropic Glutamate Receptor 2 Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Metabotropic Glutamate Receptor 2 Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Metabotropic Glutamate Receptor 2 Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2019-2024)
6.3 Global Metabotropic Glutamate Receptor 2 Market Size Market Share by Type (2019-2024)
6.4 Global Metabotropic Glutamate Receptor 2 Price by Type (2019-2024)
7 Metabotropic Glutamate Receptor 2 Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Metabotropic Glutamate Receptor 2 Market Sales by Application (2019-2024)
7.3 Global Metabotropic Glutamate Receptor 2 Market Size (M USD) by Application (2019-2024)
7.4 Global Metabotropic Glutamate Receptor 2 Sales Growth Rate by Application (2019-2024)
8 Metabotropic Glutamate Receptor 2 Market Segmentation by Region
8.1 Global Metabotropic Glutamate Receptor 2 Sales by Region
8.1.1 Global Metabotropic Glutamate Receptor 2 Sales by Region
8.1.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region
8.2 North America
8.2.1 North America Metabotropic Glutamate Receptor 2 Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Metabotropic Glutamate Receptor 2 Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Metabotropic Glutamate Receptor 2 Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Addex Therapeutics Ltd
9.1.1 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Basic Information
9.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Overview
9.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Market Performance
9.1.4 Addex Therapeutics Ltd Business Overview
9.1.5 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 SWOT Analysis
9.1.6 Addex Therapeutics Ltd Recent Developments
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Basic Information
9.2.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Overview
9.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Market Performance
9.2.4 Bristol-Myers Squibb Company Business Overview
9.2.5 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 SWOT Analysis
9.2.6 Bristol-Myers Squibb Company Recent Developments
9.3 Denovo Biopharma LLC
9.3.1 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Basic Information
9.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Overview
9.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Market Performance
9.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 SWOT Analysis
9.3.5 Denovo Biopharma LLC Business Overview
9.3.6 Denovo Biopharma LLC Recent Developments
9.4 Domain Therapeutics SA
9.4.1 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Basic Information
9.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Overview
9.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Market Performance
9.4.4 Domain Therapeutics SA Business Overview
9.4.5 Domain Therapeutics SA Recent Developments
9.5 Eli Lilly and Company
9.5.1 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Basic Information
9.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Overview
9.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Market Performance
9.5.4 Eli Lilly and Company Business Overview
9.5.5 Eli Lilly and Company Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Metabotropic Glutamate Receptor 2 Basic Information
9.6.2 Johnson and Johnson Metabotropic Glutamate Receptor 2 Product Overview
9.6.3 Johnson and Johnson Metabotropic Glutamate Receptor 2 Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Merck and Co Inc
9.7.1 Merck and Co Inc Metabotropic Glutamate Receptor 2 Basic Information
9.7.2 Merck and Co Inc Metabotropic Glutamate Receptor 2 Product Overview
9.7.3 Merck and Co Inc Metabotropic Glutamate Receptor 2 Product Market Performance
9.7.4 Merck and Co Inc Business Overview
9.7.5 Merck and Co Inc Recent Developments
10 Metabotropic Glutamate Receptor 2 Market Forecast by Region
10.1 Global Metabotropic Glutamate Receptor 2 Market Size Forecast
10.2 Global Metabotropic Glutamate Receptor 2 Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Metabotropic Glutamate Receptor 2 Market Size Forecast by Country
10.2.3 Asia Pacific Metabotropic Glutamate Receptor 2 Market Size Forecast by Region
10.2.4 South America Metabotropic Glutamate Receptor 2 Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Metabotropic Glutamate Receptor 2 by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Metabotropic Glutamate Receptor 2 Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Metabotropic Glutamate Receptor 2 by Type (2025-2030)
11.1.2 Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Metabotropic Glutamate Receptor 2 by Type (2025-2030)
11.2 Global Metabotropic Glutamate Receptor 2 Market Forecast by Application (2025-2030)
11.2.1 Global Metabotropic Glutamate Receptor 2 Sales (Kilotons) Forecast by Application
11.2.2 Global Metabotropic Glutamate Receptor 2 Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Metabotropic Glutamate Receptor 2 Market Size Comparison by Region (M USD)
Table 5. Global Metabotropic Glutamate Receptor 2 Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Metabotropic Glutamate Receptor 2 Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2022)
Table 10. Global Market Metabotropic Glutamate Receptor 2 Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Metabotropic Glutamate Receptor 2 Sales Sites and Area Served
Table 12. Manufacturers Metabotropic Glutamate Receptor 2 Product Type
Table 13. Global Metabotropic Glutamate Receptor 2 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Metabotropic Glutamate Receptor 2
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Metabotropic Glutamate Receptor 2 Market Challenges
Table 22. Global Metabotropic Glutamate Receptor 2 Sales by Type (Kilotons)
Table 23. Global Metabotropic Glutamate Receptor 2 Market Size by Type (M USD)
Table 24. Global Metabotropic Glutamate Receptor 2 Sales (Kilotons) by Type (2019-2024)
Table 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2019-2024)
Table 26. Global Metabotropic Glutamate Receptor 2 Market Size (M USD) by Type (2019-2024)
Table 27. Global Metabotropic Glutamate Receptor 2 Market Size Share by Type (2019-2024)
Table 28. Global Metabotropic Glutamate Receptor 2 Price (USD/Ton) by Type (2019-2024)
Table 29. Global Metabotropic Glutamate Receptor 2 Sales (Kilotons) by Application
Table 30. Global Metabotropic Glutamate Receptor 2 Market Size by Application
Table 31. Global Metabotropic Glutamate Receptor 2 Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2019-2024)
Table 33. Global Metabotropic Glutamate Receptor 2 Sales by Application (2019-2024) & (M USD)
Table 34. Global Metabotropic Glutamate Receptor 2 Market Share by Application (2019-2024)
Table 35. Global Metabotropic Glutamate Receptor 2 Sales Growth Rate by Application (2019-2024)
Table 36. Global Metabotropic Glutamate Receptor 2 Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2019-2024)
Table 38. North America Metabotropic Glutamate Receptor 2 Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Metabotropic Glutamate Receptor 2 Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Region (2019-2024) & (Kilotons)
Table 43. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Basic Information
Table 44. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Overview
Table 45. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Addex Therapeutics Ltd Business Overview
Table 47. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 SWOT Analysis
Table 48. Addex Therapeutics Ltd Recent Developments
Table 49. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Basic Information
Table 50. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Overview
Table 51. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 SWOT Analysis
Table 54. Bristol-Myers Squibb Company Recent Developments
Table 55. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Basic Information
Table 56. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Overview
Table 57. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 SWOT Analysis
Table 59. Denovo Biopharma LLC Business Overview
Table 60. Denovo Biopharma LLC Recent Developments
Table 61. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Basic Information
Table 62. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Overview
Table 63. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Domain Therapeutics SA Business Overview
Table 65. Domain Therapeutics SA Recent Developments
Table 66. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Basic Information
Table 67. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Overview
Table 68. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Recent Developments
Table 71. Johnson and Johnson Metabotropic Glutamate Receptor 2 Basic Information
Table 72. Johnson and Johnson Metabotropic Glutamate Receptor 2 Product Overview
Table 73. Johnson and Johnson Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson Business Overview
Table 75. Johnson and Johnson Recent Developments
Table 76. Merck and Co Inc Metabotropic Glutamate Receptor 2 Basic Information
Table 77. Merck and Co Inc Metabotropic Glutamate Receptor 2 Product Overview
Table 78. Merck and Co Inc Metabotropic Glutamate Receptor 2 Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Merck and Co Inc Business Overview
Table 80. Merck and Co Inc Recent Developments
Table 81. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Metabotropic Glutamate Receptor 2 Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Metabotropic Glutamate Receptor 2 Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Metabotropic Glutamate Receptor 2 Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Metabotropic Glutamate Receptor 2 Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Metabotropic Glutamate Receptor 2 Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Metabotropic Glutamate Receptor 2 Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Metabotropic Glutamate Receptor 2 Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Metabotropic Glutamate Receptor 2
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Metabotropic Glutamate Receptor 2 Market Size (M USD), 2019-2030
Figure 5. Global Metabotropic Glutamate Receptor 2 Market Size (M USD) (2019-2030)
Figure 6. Global Metabotropic Glutamate Receptor 2 Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Metabotropic Glutamate Receptor 2 Market Size by Country (M USD)
Figure 11. Metabotropic Glutamate Receptor 2 Sales Share by Manufacturers in 2023
Figure 12. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers in 2023
Figure 13. Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Metabotropic Glutamate Receptor 2 Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Metabotropic Glutamate Receptor 2 Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Metabotropic Glutamate Receptor 2 Market Share by Type
Figure 18. Sales Market Share of Metabotropic Glutamate Receptor 2 by Type (2019-2024)
Figure 19. Sales Market Share of Metabotropic Glutamate Receptor 2 by Type in 2023
Figure 20. Market Size Share of Metabotropic Glutamate Receptor 2 by Type (2019-2024)
Figure 21. Market Size Market Share of Metabotropic Glutamate Receptor 2 by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Metabotropic Glutamate Receptor 2 Market Share by Application
Figure 24. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2019-2024)
Figure 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application in 2023
Figure 26. Global Metabotropic Glutamate Receptor 2 Market Share by Application (2019-2024)
Figure 27. Global Metabotropic Glutamate Receptor 2 Market Share by Application in 2023
Figure 28. Global Metabotropic Glutamate Receptor 2 Sales Growth Rate by Application (2019-2024)
Figure 29. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2019-2024)
Figure 30. North America Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2023
Figure 32. U.S. Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Metabotropic Glutamate Receptor 2 Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Metabotropic Glutamate Receptor 2 Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2023
Figure 37. Germany Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Metabotropic Glutamate Receptor 2 Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Region in 2023
Figure 44. China Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Metabotropic Glutamate Receptor 2 Sales and Growth Rate (Kilotons)
Figure 50. South America Metabotropic Glutamate Receptor 2 Sales Market Share by Country in 2023
Figure 51. Brazil Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Metabotropic Glutamate Receptor 2 Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Metabotropic Glutamate Receptor 2 Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Metabotropic Glutamate Receptor 2 Market Share Forecast by Type (2025-2030)
Figure 65. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Application (2025-2030)
Figure 66. Global Metabotropic Glutamate Receptor 2 Market Share Forecast by Application (2025-2030)
